When does the weight loss plateau occur on drugs like Ozempic, and can you delay it?

Health & Lifestyle
174

Listen to article (english)

Translate to Spanish or other 102 languages!

When is a person likely to reach a weight loss plateau on GLP-1 agonists vs surgery vs dietary interventions? Image for illustration purposes
When is a person likely to reach a weight loss plateau on GLP-1 agonists vs surgery vs dietary interventions? Image for illustration purposes

Medical News Today

- Advertisement -
  • A new study investigated why different obesity treatments, including diets, surgeries and new medications like GLP-1 receptor agonists, such as semaglutide and tirzepatide, lead to varying times at which weight loss plateaus.
  • Utilizing a mathematical model, the research examines how these interventions alter the body’s regulation of energy intake and expenditure, affecting the duration of effective weight loss.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/when-does-the-loss-plateau-occur-on-drugs-like-ozempic-and-can-you-delay-it

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Vaccines for Family & Caregivers 
Next article
Weight-Loss Surgery Before Kidney Transplantation Improves Health & Eligibility of Patients with Obesity & Renal Failure

More Articles

USDA “Real Food First” Rule Doubles Stocking Requirements for SNAP Retailers

The U.S. Department of Agriculture (USDA) published the final rule regarding stocking standards for retailers participating in the Supplemental Nutrition Assistance Program (SNAP), ensuring a broader variety of nutritious food is available to SNAP participants at authorized retailers across the country.

Why Older Adults are Choosing Edibles Over Pills

For adults over 60, cannabis use is increasing faster than in any other demographic.

Ultrasonic Needles Triple the Yield of Cancer Biopsies

Mega Doctor News by Aalto University Newswise — Developed at Aalto University over several years,...

Scientists Reveal the “Hidden Entryway” Gut Bacteria Use to Spark Tumors

Since a landmark 2009 study, researchers have known that a common gut bacterium, Bacteroides fragilis, drives colon tumor formation, potentially leading to colorectal cancer, by secreting a toxin that damages the lining of the colon. But until now, the exact mechanism the toxin uses to latch onto those cells remained a mystery.
- Advertisement -